Uncategorized
Second Sight Reports First Quarter 2018 Financial Results
LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today reported financial results for the three months ended March 31, 2018. Recent Corporate Highlights: Completed $10 million private placement on May 3, 2018 of 6,756,757 shares of common stock priced at $1.48, the closing pri